Press Release February 10, 2022French Business Leaders Are Optimistic About Growth Despite Labor Shortages, Inaugural J.P. Morgan Survey Finds 0 0 Share
Press Release February 10, 2022Verizon returns to Super Bowl to spotlight new 5G Internet expansion 0 0 Share
Press Release February 10, 2022Medexus Pharmaceuticals Generated $21.3M in Fiscal 2022 Third Quarter Revenues and Achieved $1.9M Positive EBITDA for the Three Months Ended December 31, 2021 0 0 Share
Press Release February 10, 2022NEW ORIENTAL ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against New Oriental Education & Technology Group, Inc. and Encourages Investors to Contact the Firm 0 0 Share
Press Release February 10, 2022HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Bumble (BMBL) Investors with Losses to Contact Firm's Attorneys, Lead Plaintiff Opportunity in Securities Fraud Action 0 0 Share
Press Release February 10, 2022Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of Bumble Inc. (BMBL) Investors and Encourages Investors to Contact the Firm Before March 25, 2022 0 0 Share
Press Release February 10, 2022Moderna Chief Technical Operations and Quality Officer Juan Andres Elected to National Academy of Engineering 0 0 Share
Press Release February 10, 2022FDA Accepts Dupixent® (dupilumab) for Priority Review in Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis 0 0 Share
Press Release February 10, 2022FDA accepts Dupixent® (dupilumab) for Priority Review in children aged 6 months to 5 years with moderate-to-severe atopic dermatitis 0 0 Share
Press Release February 9, 2022HONEYWELL INTRODUCES NEW TECHNOLOGY TO PRODUCE KEY FEEDSTOCK FOR PLASTICS 0 0 Share
